Pharma Solutions
Overview
Cardio Metabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
LiverMultiScan
MRCP+
CoverScan
Hepatica
Perspectum Portal
Research
Overview
Publications
Research Projects
Research Network
company
Overview
Senior Management
Board of Directors
Company News
Careers
Events
Webinars
Media Center
OUR LOCATIONS
< RETURN TO RESEARCHERS
Publications
Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Filter by disease type
Any
Filter by product
Any
Search:
placeholder
clear filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Comparison of liver T1 relaxation times without and with iron correction in pediatric autoimmune liver disease
Author:
Dillman, J. R., Serai, S. D., Miethke, A. G., Singh, R., Tkach, J. A., Trout, A. T.
Journal:
Pediatric Radiology
Publication Year:
2020
Volume/Issue:
50(7)
Pages:
935–942.
New boundaries of liver imaging: from morphology to function
Author:
Cruz, M., Ferreira, A. A., Papanikolaou, N., Banerjee, R., Alves, F. C.
Journal:
European Journal of Internal Medicine
Publication Year:
2020
Volume/Issue:
79
Pages:
12-22
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes
Author:
Hydes, T. J., Summers, N., Brown, E., Alam, U., Thomaides-Brears, H., Wilding, J., & Cuthbertson, D. J.
Journal:
Diabetic medicine
Publication Year:
2020
Volume/Issue:
37(11)
Pages:
1793–1806
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease
Author:
Jayaswal, A., Levick, C., Selvaraj, E. A., Dennis, A., Booth, J. C., Collier, J., Cobbold, J., Tunnicliffe, E. M., Kelly, M., Barnes, E., Neubauer, S., Banerjee, R., & Pavlides, M.
Journal:
Liver international
Publication Year:
2020
Volume/Issue:
40(12)
Pages:
3071-3082
1
...
18 / 27
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD